MEDIA RELEASE Fiasp insulin to remain on the Pharmaceutical Benefits Scheme The new listing of Fiasp® Penfill® on the Pharmaceutical Benefits Scheme will keep the life-saving medication available to the 15,000+ Australians who rely on it Sydney, 18 September 2023: JDRF Australia is welcoming an announcement from Minister for Health, Hon Mark Butler, that Fiasp […]
Ethan Greenfield has been living with type 1 diabetes (T1D) for seven years, after being diagnosed at just four years old. Since then, Ethan, mum Kylie, and the Greenfield family have been fiercely advocating for the T1D community on behalf of JDRF, helping key decision makers like their local Boothby Member Louise Miller-Frost and Minister […]
MEDIA RELEASE JDRF Australia welcomes Government’s decision to extend availability of Fiasp insulin on the Pharmaceutical Benefits Scheme The move will keep the life-saving medication in the hands of the 15,000+ people who rely on it for a further six months Sydney, 17 March 2023: JDRF Australia is today welcoming an announcement by the Albanese […]